Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-07

Clinical Trial Update: Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003 [Phase 2]

View source ↗

Summary

Extension study results for Proellex in women with uterine fibroids completed Phase 2 with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Proellex (telapristone acetate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Uterine Fibroids | Phase 2 | Status: COMPLETED | Results posted: 2011-01-07